Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 70% · prior close shown (market closed)
BIO-TECHNE Corp shows stable business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue +1% YoY in Q4 FY2026.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 1d ago
TECH's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on TECH.
Free accounts see more of this; Premium sees all of it.
Reported figures for BIO-TECHNE Corp — research only, not investment advice.
Updated
What happened recently for BIO-TECHNE Corp (TECH) — events, not interpretation.
Research & analysis only — not investment advice.
Held in ETFsweight · est. sleeve dollars
AlphaOS industries
Investment snapshot
TECH's AI investment thesis
Upgrade to Premium for TECH's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Prior close
$72.51
Market cap
$11.37B
Profitable
Yes
Revenue $321.19M
Net income
$54.62M
FY Sep 25, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for BIO-TECHNE Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow BIO-TECHNE Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.
Structured stock intelligence for companies connected to this research.